Regulations and Compliance
-
Strategies To Reduce Regulatory Risks In Gene Therapy
5/15/2020
Learn how to mitigate regulatory risk for your gene therapy process.
-
Lower Variability For Viral Titer Determination
1/11/2023
Learn about the benefits of ddPCR for ensuring precise and reproducible viral titers in the development of effective adeno-associated virus AAV-based gene therapies.
-
Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond
12/17/2024
In this executive roundtable discussion, Bioprocess Online editor Tyler Menichiello is joined by CEO, co-founder, and president of Ossium Health, Kevin Caldwell, CSO of FibroBiologics, Hamid Khoja, Ph.D., and president and acting CEO of Triumvira Immunologics, Rob Williamson. The panelists share their predictions and thoughts on the industry’s direction heading into 2025. They cover manufacturing trends (noting opportunities for improvements in cell therapy manufacturing), AI adoption, regulatory concerns, and the potentially challenging funding environment ahead.
-
Simplifying Bioprocess Data Collection
2/17/2023
Centralized bioprocess data collection and aggregation lowers the risk of data loss during any manual retrieval process. Discover a solution that helps you meet data storage and reporting requirements.